Table 4 Comparison of emergency aSAH patients with/without COVID-19 NAT
Characteristics | Absent | Accept | P valuea |
|---|---|---|---|
No. of patients | 30 | 12 | Â |
No. of aneurysms | 32 | 13 | Â |
Sex (male) | 16 (53.3) | 8 (66.7) | 0.430 |
Age, years | 55.1 ± 8.3 | 54.5 ± 9.5 | 0.840 |
Admission stratification | |||
 Normal patient | 26 (86.7) | 8 (66.7) | 0.151 |
 Mild suspected patient | 4 (13.3) | 4 (33.3) | |
 Suspected patient | 0 (0.0) | 0 (0.0) | |
 Confirmed patient | 0 (0.0) | 0 (0.0) | |
Location of responsible aneurysm | |||
 ACoA | 8 (26.7) | 5 (41.7) | 0.675 |
 PCoA | 11 (36.7) | 4 (33.3) | |
 ACA | 1 (3.3) | 1 (8.3) | |
 MCA | 9 (30.0) | 2 (16.7) | |
 Others | 1 (3.3) | 0 (0.0) | |
Fisher grade | 3.2 ± 1.0 | 2.9 ± 1.2 | 0.442 |
Modified Fisher grade | 3.2 ± 1.1 | 2.8 ± 1.1 | 0.264 |
Hunt-Hess grade | 1.9 ± 0.5 | 1.9 ± 0.5 | 0.928 |
WFNS grade | 2.7 ± 0.9 | 2.8 ± 1.0 | 0.601 |
GCS | 12.8 ± 1.3 | 13.1 ± 1.0 | 0.550 |
Duration between rupture and craniotomy, h | 71.7 ± 55.3 | 70.0 ± 57.4 | 0.931 |
Duration between admission and craniotomy, h | 35.9 ± 15.3 | 40.2 ± 20.4 | 0.453 |
Preoperative hospitalized adverse events | |||
 Rebleeding | 0 (0.0) | 0 (0.0) | > 0.99 |
 Infarction | 0 (0.0) | 0 (0.0) | > 0.99 |
 Epilepsy | 1 (3.3) | 1 (8.3) | 0.513 |
Duration of surgery, h | 3.5 ± 0.9 | 3.5 ± 1.2 | 0.913 |
Intraoperative blood loss, ml | 236.7 ± 130.6 | 320.8 ± 400.8 | 0.490 |
Mean hospital LOS, days | 14.4 ± 9.7 | 16.3 ± 6.4 | 0.547 |
Hospitalization cost, dollarsb | 14,268.4 ± 7811.7 | 11,178.5 ± 3596.8 | 0.198 |
Postoperative complications | |||
 Postoperative hemorrhage | 0 (0.0) | 0 (0.0) | > 0.99 |
 Postoperative DCI | 9 (30.0) | 4 (33.3) | 0.833 |
 Postoperative DVT | 8 (26.7) | 2 (16.7) | 0.481 |
 Postoperative intracranial infection | 3 (10.0) | 2 (16.7) | 0.558 |
Discharge mRS score | |||
 Mean | 2.0 ± 1.6 | 1.8 ± 1.5 | 0.653 |
 0–2 | 20 (66.7) | 9 (75.0) | 0.874 |
 3–6 | 10 (33.3) | 3 (25.0) | |